BridgeBio to Participate in November Investor Conferences

Core Insights - BridgeBio Pharma, Inc. is a biopharmaceutical company focused on developing transformative medicines for genetic diseases [2] - The company will participate in healthcare investor conferences, hosting fireside chats to engage with investors [1][3] Company Overview - Founded in 2015, BridgeBio aims to discover, create, test, and deliver medicines for patients with genetic diseases [2] - The company's pipeline includes programs from early science to advanced clinical trials, showcasing its commitment to genetic medicine [2] Upcoming Events - BridgeBio will host a fireside chat at the UBS Global Healthcare Conference on November 10 at 1:15 pm EST [3] - The company will also participate in the Jefferies Global Healthcare Conference on November 18 at 11:00 am EST [3]